BCPC vs PAHC
BCPC: Balchem is a specialty chemicals and nutrition ingredients manufacturer serving human nutrition, animal feed, food systems, and industrial sterilization markets with microencapsulation and chelation technologies. PAHC: Phibro manufactures and distributes nutritional additives, pharmaceutical products, and specialty ingredients for animal health and nutritional enhancement worldwide.
Side-by-side fundamentals
| Metric | BCPC | PAHC | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $162.10 | $33.81 | |
| Market cap as of 2026-07-23 | $5.2B | $1.4B | |
| P/E as of 2026-07-23 | 32.73 | 14.42 | PAHC lower |
| PEG as of 2026-07-23 | 1.99 | 0.62 | PAHC lower |
| Net margin as of 2026-07-23 | +14.9% | +6.3% | BCPC higher |
| Gross margin as of 2026-07-23 | +36.3% | +32.8% | BCPC higher |
| Operating margin as of 2026-07-23 | +20.2% | +12.0% | BCPC higher |
| ROE as of 2026-07-23 | +12.4% | +29.5% | PAHC higher |
| ROA as of 2026-07-23 | +9.4% | +6.8% | BCPC higher |
| Debt / equity as of 2026-07-23 | 0.13 | 2.03 | BCPC lower |
| Revenue growth (YoY) as of 2026-07-23 | +9.6% | +26.0% | PAHC higher |
| Revenue CAGR (3y) SEC XBRL | +3.2% | +11.2% | PAHC higher |
| Dividend yield as of 2026-07-23 | +0.6% | +1.4% | PAHC higher |
| Dividend streak (yrs) SEC XBRL | 4 | 5 | PAHC higher |
| Beta as of 2026-07-23 | 0.82 | 0.48 | |
| 1-year return as of 2026-07-22 close | +5.3% | +15.7% | PAHC higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.